NMR for sample quality assessment in metabolomics

N Biotechnol. 2019 Sep 25:52:25-34. doi: 10.1016/j.nbt.2019.04.004. Epub 2019 Apr 22.

Abstract

The EU Framework 7 project SPIDIA was the occasion for development of NMR approaches to evaluate the impact of different pre-analytical treatments on the quality of biological samples dedicated to metabolomics. Systematic simulation of different pre-analytical procedures was performed on urine and blood serum and plasma. Here we review the key aspects of these studies that have led to the development of CEN technical specifications, to be translated into ISO/IS in the course of the EU Horizon 2020 project SPIDIA4P. Inspired by the SPIDIA results, follow-up research was performed, extending the analysis to different sample types and to the different effects of long-term storage. The latter activity was in conjunction with the local European da Vinci Biobank. These results (which partially contributed to the ANNEX of CEN/TS 16945"MOLECULAR IN VITRO DIAGNOSTIC EXAMINATIONS - SPECIFICATIONS FOR PRE-EXAMINATION PROCESSES FOR METABOLOMICS IN URINE, VENOUS BLOOD SERUM AND PLASMA") are presented in detail.

Keywords: Plasma; Pre-analytics; Serum; Urine.

MeSH terms

  • Humans
  • Magnetic Resonance Spectroscopy*
  • Metabolomics*
  • Quality Control
  • Serum / chemistry
  • Time Factors